Similar to breast cancer, STAT5 also has a dual role in HCC, where it can act as a tumour suppressor to counteract the tumorigenic effects of STAT3 signalling or as an oncogene in other circumstances. This evidence concerns the gene STAT5A and hepatocellular carcinoma.